Estrogen receptor alpha (ERα), the hormone (β‐estradiol)‐sensing nuclear receptor frequently overexpressed in breast cancer, is heavily post‐translationally modified, including 26 phosphorylated residues (Hornbeck et al, 2012). The gene discussed is ESR1; the disease is breast cancer.